Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …

This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …

Weeks and months after the onset of acute COVID-19, people continue to suffer. Paul Garner,
a professor of epidemiology at Liverpool School of Tropical Medicine, UK, wrote on the …

Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

… Bruchfeld and Fedorowski contributed equally to this work and are joint senior authors. …
Bruchfeld and Fedorowski contributed equally to this work and are joint senior authors. …

Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS) constitute the main burden of infectious disease in resource-limited countries. …

Rationale: In the absence of active tuberculosis, a positive tuberculin skin test (TST) or
interferon-γ release assay (IGRA) result defines latent infection with Mycobacterium tuberculosis, …

Objectives Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the
setting, we aimed to determine the associations of risk factors of MDR-TB across different …

The World Health Organization (WHO) recommends that countries implement pharmacovigilance
and collect information on active drug safety monitoring (aDSM) and management of …